Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
June, 2026
June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Rehan Khan Explores Streptokinase
Rehan Khan/LinkedIn
Jun 11, 2026, 22:30

Rehan Khan Explores Streptokinase

Rehan Khan, Hospital Pharmacist and Manager Auctus Hospital, shared on LinkedIn:

Did you know?

Day 160/365 – Medicine of the Day: Streptokinase

Streptokinase is a thrombolytic (fibrinolytic) agent that helps dissolve dangerous blood clots by activating plasminogen and converting it into plasmin, which breaks down fibrin clots.

It has been widely used in acute thromboembolic emergencies to restore blood flow and reduce tissue damage.

  • Drug Class: Thrombolytic (Fibrinolytic Agent), Plasminogen Activator
  • Uses: Acute STEMI, Massive Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Arterial Thromboembolism
  • MOA: Forms a complex with plasminogen → Converts plasminogen to plasmin → Degrades fibrin clots → Restores blood flow
  • Dose: STEMI: 1.5 million IU IV infusion over 60 minutes (dose varies by indication)
  • Adverse Effects: Bleeding, Hypotension, Allergic Reactions, Fever, Rare Hemorrhagic Stroke
  • Contraindications: Active internal bleeding, Recent hemorrhagic stroke, Major recent surgery or trauma
  • Drug Interactions: Anticoagulants, Antiplatelets, Other thrombolytics, NSAIDs (↑ bleeding risk)
  • Brand Names: Streptase, Kabikinase, Thromboflux

Clinical Pearl:

Streptokinase rapidly dissolves thrombi by promoting plasmin formation.

Early administration after symptom onset significantly improves outcomes in acute myocardial infarction, but careful monitoring is essential due to the risk of serious bleeding.”

Rehan Khan

Stay updated with Hemostasis Today.

Health Hematology Hemostasis Hemostasis News Hemostasis Today Medicine Rehan Khan Streptokinase
NewsFeed